
Seed-stage venture firm backing technical founders whose software reaches the physical world

Investment firm that mentors entrepreneurs and backs technology and life science start-ups

RONA Holdings, LLC calls itself a unique investment firm that focuses on developing and mentoring entrepreneurs so that they build companies with global impact. Its stated mission is to give ambitious founders resources and hands-on mentorship so that they can build innovative, disruptive answers to society's problems. It says it is passionate about high-impact products and services built on groundbreaking technology.
The firm presents its holdings as a list of startups it has had a role in, and the range is wide. Its holdings touch genomics, biotechnology, health data, agriculture and water software, chips, wearable devices, algae, streaming data, legal services and consumer retail. A selection shows how varied it is:
A good part of the list records outcomes. Aquantia, a maker of high-speed chips for moving data inside data centers, went public in 2017. Apixio, which draws insight from textual, scanned and coded health data, was bought by Centene. BaseHealth, maker of the Genophen health management platform, was acquired by Genalyte in 2020. Bina Technologies went to Roche in 2014, and Avantome and NextBio were acquired by illumina, in 2008 and 2013. Clever Sense, a personalization platform, was bought by Google in 2011. Other acquirers named include Reliance Holding USA for Aurora Algae, Thermo Fisher Scientific for IntegenX, RSA for PassBan, Vistaprint for the website builder Webs, and LinkedIn for the legal marketplace UpCounsel.
The mix of public listings and acquisitions gives a picture of a firm that stays with companies over many years, from first idea to sale or flotation.
RONAholdings, which trades as RONA Holdings, LLC, is an investment firm that develops and mentors entrepreneurs. It provides resources and hands-on guidance to founders building companies aimed at society's problems. Its site lists a portfolio of start-ups, several of which have since listed or been bought.
The portfolio spans biotechnology, genetics, health data, food and water analytics, semiconductors, wearables, algae and data streaming. Named examples include Adaptive Biotechnologies, which went public in 2019, Apixio, bought by Centene, BaseHealth, bought by Genalyte, and Clear Labs and Color, which are still described as independent.
Summary written by TrustList from the business's own published information, Nov 2026.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about RONAholdings.
Similar listings buyers compare against this one.

Seed-stage venture firm backing technical founders whose software reaches the physical world

Seed-stage venture arm of Thorgate that backs early technology teams, mostly building scalable business software

Singapore-registered fund manager investing in growth-stage technology companies in India and South East Asia

Venture investor backing early technology startups in Western Europe and the Nordics

Toronto venture arm of a private investment firm backing emerging companies and venture platforms worldwide

Venture capital firm with a portfolio spanning tutoring, healthcare, recruiting, trucking safety, policing and sports software
Everything here links back to the same verified catalogue. Pick your next stop.